
WELL
Welltower Inc
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
188.940
Open
187.090
VWAP
187.77
Vol
3.83M
Mkt Cap
128.86B
Low
185.420
Amount
718.55M
EV/EBITDA(TTM)
38.04
Total Shares
597.92M
EV
138.61B
EV/OCF(TTM)
49.74
P/S(TTM)
12.42
Welltower Inc. is a residential wellness and healthcare infrastructure company. It seeks to position its portfolio of 1,500 plus seniors and wellness housing communities at the intersection of housing, healthcare, and hospitality, creating communities for mature renters and older adults in the United States, United Kingdom, and Canada. Its segments include Seniors Housing Operating, Triple-net and Outpatient Medical. Its seniors housing operating properties include seniors apartments, assisted living communities, independent living/continuing care retirement communities, independent supportive living communities (Canada), care homes with and without nursing (United Kingdom) and combinations thereof. Its triple-net properties include the property types that are under seniors housing operating properties, as well as long-term/post-acute care facilities. Its outpatient medical portfolio is primarily self-managed and consists of multi-tenant properties leased to healthcare providers.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q2
FY2026Q1
FY2025Q4
3.07B
+20.3%
0.596
+32.46%
2.96B
+22.19%
0.580
+44.96%
2.83B
+25.6%
0.385
+102.54%
Estimates Revision
The market is revising Downward the revenue expectations for Welltower Inc. (WELL) for FY2025, with the revenue forecasts being adjusted by -0.68% over the past three months. During the same period, the stock price has changed by 11.13%.
Revenue Estimates for FY2025
Revise Downward

-0.68%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward

+4.46%
In Past 3 Month
Stock Price
Go Up

+11.13%
In Past 3 Month
15 Analyst Rating
2.79% Upside
Wall Street analysts forecast WELL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for WELL is 193.00 USD with a low forecast of 167.00 USD and a high forecast of 246.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Buy
2 Hold
0 Sell
Strong Buy
2.79% Upside
Current: 187.760
Low
167.00
Averages
193.00
High
246.00
2.79% Upside
Current: 187.760
Low
167.00
Averages
193.00
High
246.00
Evercore ISI
In Line -> Outperform
upgrade
$183 -> $208
2025-11-05
New
Reason
Evercore ISI
Price Target
$183 -> $208
2025-11-05
New
upgrade
In Line -> Outperform
Reason
Evercore ISI upgraded Welltower to Outperform from In Line with a price target of $208, up from $183, following a "very strong" Q3 report last week. The surge in accretive investment in volume "easily surpassed our expectations" and triggered a step function increase in run-rate earnings, says the analyst, who raised the firm's 2025, 2026 and 2027 estimates as a result.
Cantor Fitzgerald
Overweight
maintain
$195 -> $200
2025-10-31
Reason
Cantor Fitzgerald
Price Target
$195 -> $200
2025-10-31
maintain
Overweight
Reason
Cantor Fitzgerald raised the firm's price target on Welltower to $200 from $195 and keeps an Overweight rating on the shares. The company produced "solid" results for Q3 and raised guidance to close out 2025, the analyst tells investors in a research note. The firm is a believer in the senior housing growth story with a trajectory of growing demand for the next 10-20 years.
Freedom Capital
Viacheslav Obodnikov
Buy -> Hold
downgrade
$182 -> $196
2025-10-29
Reason
Freedom Capital
Viacheslav Obodnikov
Price Target
$182 -> $196
2025-10-29
downgrade
Buy -> Hold
Reason
Freedom Capital analyst Viacheslav Obodnikov downgraded Welltower to Hold from Buy with a price target of $196, up from $182. Welltower delivered a "strong" third quarter and also announced a landmark $23B in new transactions, accelerating its transformation into a pure-play seniors housing platform, which enhances long-term growth prospects. The firm is raising its price target to reflect the improved outlook, but downgrading on valuation given the stock's recent appreciation and dilutive growth in 2026.
UBS
Michael Goldsmith
Buy
maintain
$195 -> $203
2025-10-29
Reason
UBS
Michael Goldsmith
Price Target
$195 -> $203
2025-10-29
maintain
Buy
Reason
UBS analyst Michael Goldsmith raised the firm's price target on Welltower to $203 from $195 and keeps a Buy rating on the shares. Welltower streamlining its organization around its senior housing platform is prudent, as increasing the emphasis around it should only increase its productivity, the analyst tells investors in a research note. UBS sees forecasts continuing to move higher.
Wells Fargo
Overweight
maintain
$185 -> $200
2025-10-21
Reason
Wells Fargo
Price Target
$185 -> $200
2025-10-21
maintain
Overweight
Reason
Wells Fargo raised the firm's price target on Welltower to $200 from $185 and keeps an Overweight rating on the shares. The firm remains most constructive on Senior Housing as market data continues to signal strength in occupancy and rate, and broker contracts flag accelerated deal volumes.
BofA
analyst
Buy
maintain
$240 -> $246
2025-10-17
Reason
BofA
analyst
Price Target
$240 -> $246
2025-10-17
maintain
Buy
Reason
BofA raised the firm's price target on Welltower (WELL) to $246 from $240 and keeps a Buy rating on the shares. A "silver tsunami' in the U.S. is expected to to drive big gains for the major players in the senior housing business as Boomers age into senior living, says the analyst, who forecasts that margins for the five SHOP REITs- Welltower, Ventas (VTR), Sabra (SBRA), American Healthcare REIT (AHR) and National Health Investor (NHI) - will expand ahead of Street estimates in 2026.
See All Ratings
Valuation Metrics
The current forward P/E ratio for Welltower Inc (WELL.N) is 85.60, compared to its 5-year average forward P/E of 93.86. For a more detailed relative valuation and DCF analysis to assess Welltower Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Fair
5Y Average PE
93.86
Current PE
85.60
Overvalued PE
122.53
Undervalued PE
65.19
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued
5Y Average EV/EBITDA
24.27
Current EV/EBITDA
29.17
Overvalued EV/EBITDA
26.96
Undervalued EV/EBITDA
21.59
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A
5Y Average PS
7.73
Current PS
186.35
Overvalued PS
19.02
Undervalued PS
-3.56
Financials
Annual
Quarterly
FY2025Q3
YoY :
+30.65%
2.69B
Total Revenue
FY2025Q3
YoY :
+45.44%
489.92M
Operating Profit
FY2025Q3
YoY :
+54.20%
290.77M
Net Income after Tax
FY2025Q3
YoY :
-43.84%
0.41
EPS - Diluted
FY2025Q3
YoY :
+25.31%
858.36M
Free Cash Flow
FY2025Q3
YoY :
+4.40%
22.30
Gross Profit Margin - %
FY2025Q3
YoY :
+1.85%
28.12
FCF Margin - %
FY2025Q3
YoY :
+15.37%
10.36
Net Margin - %
FY2025Q3
YoY :
-12.17%
3.03
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
286.4K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
1
3.0M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 104.41% over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
1.5M
Volume
8
0-12
Months
653.3K
Volume
6
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
4
1.5M
Volume
Months
0-12
9
740.8K
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
286.4K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
1
3.0M
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
WELL News & Events
Events Timeline
2025-10-27 (ET)
2025-10-27
16:15:11
Welltower announces Q3 normalized FFO of $1.34, exceeding consensus estimate of $1.30
2025-07-28 (ET)
2025-07-28
16:22:08
Welltower raises 2025 normalized FFO view to $5.06-$5.14 from $4.90-$5.04
2025-07-28
16:21:11
Welltower reports Q2 normalized FFO $1.28, consensus $1.22
Sign Up For More Events
Sign Up For More Events
News
3.0
15:51 PMCNBCJosh Brown: These 'Top Stocks' Offer Both Growth and Defense, Attracting More Customers Daily
3.0
12:42 PMBenzingaDell, Microsoft, Welltower, and Others Featured in CNBC's 'Final Trades'
3.0
11-05TipRanksGILD, COF, WELL: Today's Top 3 Stocks to Consider, Supported by Technical Analysis
Sign Up For More News
People Also Watch

CI
Cigna Group
256.380
USD
-1.23%

BTI
British American Tobacco plc
54.210
USD
+0.61%

IBKR
Interactive Brokers Group Inc
69.860
USD
-2.46%

HCA
HCA Healthcare Inc
471.360
USD
-0.39%

CTAS
Cintas Corp
184.890
USD
-0.50%

RACE
Ferrari NV
405.620
USD
-0.26%

PNC
PNC Financial Services Group Inc
182.920
USD
-0.67%

AON
Aon PLC
340.000
USD
-0.50%

DJT
Trump Media & Technology Group Corp
13.330
USD
-5.93%

CMG
Chipotle Mexican Grill Inc
30.560
USD
-4.41%
FAQ
What is Welltower Inc (WELL) stock price today?
The current price of WELL is 187.76 USD — it has increased 0.76 % in the last trading day.





